Corimmun GmbH clinical trials
Acquired by Johnson & Johnson, 2012 · source ↗
The registry lists 2 studies whose lead sponsor is Corimmun GmbH. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 17, 2014.
Before and after it joined Johnson & Johnson
- First submitted before Corimmun GmbH became part of Johnson & Johnson
- 2
- First submitted after Corimmun GmbH became part of Johnson & Johnson
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Corimmun GmbH2 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Johnson & Johnson studies →
- Pilot Study of COR-1 in Heart FailureCompletedNCT01391507Phase 2
Sponsor listed in the registry: Corimmun GmbH · First submitted before Corimmun GmbH became part of Johnson & Johnson
- Safety, Pharmacokinetic and Pharmacodynamic Study of COR-1, an Anti-ß1 Receptor Antibody CyclopeptideCompletedNCT01043146Phase 1
Sponsor listed in the registry: Corimmun GmbH · First submitted before Corimmun GmbH became part of Johnson & Johnson